Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 10/7/24 → 08/18/26 |
Funding
- United Therapeutics Corporation: $100,217.90
RIN-PF-301: A Randomized, Double-blind, Placebo-controlled, Phase 3 Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects with Idiopathic Pulmonary Fibrosis
- Desai, Alpa (PI)
- Alexander, Krystal (CoPI)
Project: Research